STERIS rises as analyst upgrade adds to momentum from raised outlook

STERIS plc (STE) is up 4.3% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears to be driven mainly by a fresh analyst upgrade, which likely reinforced bullish sentiment after STERIS delivered solid quarterly results and lifted its full-year adjusted earnings outlook last week. Investors may also be responding to signs that integration and financing concerns around the pending Xodus Medical deal are becoming more manageable.

Details:

Jefferies upgraded STERIS to Buy from Hold on November 13 and raised its price target to $305 from $232, pointing to valuation and easing headwinds.

In fiscal second-quarter results released November 4, STERIS reported revenue growth of 9% to about $1.6 billion, with adjusted diluted EPS of $2.94.

The company increased its fiscal 2027 adjusted EPS outlook to $11.35 to $11.55 from $11.10 to $11.30, citing solid operating performance and tariff refunds received year to date.

STERIS is also financing its pending acquisition of Xodus Medical, including a $1.5 billion senior notes offering, while still indicating the transaction is expected to close by December 31, 2026.

Sources:

STERIS Investor Relations, SEC, StockAnalysis

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$STE Insider Trading Activity

$STE insiders have traded $STE stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.

Here’s a breakdown of recent trading of $STE stock by insiders over the last 6 months:

MOHSEN SOHI has made 0 purchases and 3 sales selling 8,951 shares for an estimated $2,195,803.
KAREN L BURTON (Sr. Vice Pres., CFO) sold 5,880 shares for an estimated $1,503,045
DANIEL A CARESTIO (President and CEO) has made 0 purchases and 2 sales selling 4,428 shares for an estimated $946,798.
RICHARD C BREEDEN sold 1,481 shares for an estimated $310,284
JOHN ADAM ZANGERLE (Sr. VP, Gen Counsel, and Sec.) sold 1,419 shares for an estimated $296,968

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

EARLY ACCESS

Receive STE Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$STE Hedge Fund Activity

We have seen 409 institutional investors add shares of $STE stock to their portfolio, and 432 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM removed 35,102,058 shares (-99.5%) from their portfolio in Q3 2026, for an estimated $7,371,783,200
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 1,248,344 shares (-99.6%) from their portfolio in Q2 2026, for an estimated $262,863,796
FRANKLIN RESOURCES INC removed 1,182,100 shares (-95.1%) from their portfolio in Q2 2026, for an estimated $248,914,797
GOLDMAN SACHS GROUP INC added 981,568 shares (+257.2%) to their portfolio in Q2 2026, for an estimated $206,688,773
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 698,353 shares (+134.4%) to their portfolio in Q2 2026, for an estimated $147,052,191
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. removed 666,633 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $139,999,596
FINDLAY PARK PARTNERS LLP removed 657,713 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $138,126,307

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

$STE Congressional Stock Trading

Members of Congress have traded $STE stock 7 times in the past 6 months. Of those trades, 0 have been purchases and 7 have been sales.

Here’s a breakdown of recent trading of $STE stock by members of Congress over the last 6 months:

REPRESENTATIVE KEVIN HERN sold up to $50,000 on 09/15.
REPRESENTATIVE APRIL MCCLAIN DELANEY has traded it 5 times. They made 0 purchases and 5 sales worth up to $310,000 on 08/25, 07/31, 07/29, 07/27, 07/24.
REPRESENTATIVE JARED MOSKOWITZ sold up to $15,000 on 07/13.

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

$STE Analyst Ratings

Wall Street analysts have issued reports on $STE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

Jefferies issued a "Buy" rating on 11/13/2026
Keybanc issued a "Overweight" rating on 11/06/2026
UBS issued a "Buy" rating on 08/07/2026
Piper Sandler issued a "Overweight" rating on 08/07/2026

To track analyst ratings and price targets for $STE, check out Quiver Quantitative's $STE forecast page.

$STE Price Targets

Multiple analysts have issued price targets for $STE recently. We have seen 4 analysts offer price targets for $STE in the last 6 months, with a median target of $279.5.

Here are some recent targets:

David Windley from Jefferies set a target price of $305.0 on 11/13/2026
Brett Fishbin from Keybanc set a target price of $284.0 on 11/06/2026
Patrick Wood from UBS set a target price of $270.0 on 08/07/2026
Jason Bednar from Piper Sandler set a target price of $275.0 on 08/07/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.